Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease
Conditions
- Non-Alcoholic Fatty Liver Disease
- Non Alcoholic Fatty Liver
- Non Alcoholic Steatohepatitis
- NAFLD
- NASH
Interventions
- DRUG: Hyperpolarized (HP) 13C
- DRUG: Hyperpolarized 13C-Urea
- PROCEDURE: Magnetic Resonance Imaging
- PROCEDURE: Saline Flush
Sponsor
Michael Ohliger, MD PhD
Collaborators